Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 29.77

+3.7%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JanyBlueEyes who wrote (5407)	6/21/1999 9:48:00 PM
From: Bill Wexler	Read Replies (2) of 5736

The CCSI stock fraud nears its end CCSI conference call replay: Phone Number: 800-642-1687 Conference ID: 390399 Today, Darby McFarlane, CEO of CCSI and one of the primary architects of the CCSI stock fraud, effectively hung her shareholders out to dry. What was most amusing about the conference call, besides the nonstop whining from Darby about how "hard" she's "worked" all these years was the way she backpedaled away from the only two substantive questions during the whole conference - regarding if and when the company will see positive cash flow from operations, and if further dilutive financing will be required. Darby continued to make misleading comments about market size, once again trying to fraudulently promote her generic colorimeter as a viable replacement for the far less expensive and more accurate blood test. It was also interesting to note the constant references to "short raids", and the obviously set-up "question" regarding Asensio (Manuel Asensio is a New York hedge fund manager who effectively exposed the CCSI stock frauds in a series of reports last year asensio.com ) I wasn't surprised to see a flurry of posting activity from various shills with wild estimates of enormous profits and a barrage of insults directed at short-sellers. Now that the "news" is out, CCSI comes closer to being valued on earnings streams rather than absurd speculation. For a quick (but not the only) example of how big the market for infant jaundice colorimeters really is, check out the income statements of SPRX, then compare the market cap of SPRX to CCSI. CCSI promoters have deliberately misled investors into thinking that CCSI colorimeter is somehow "better" than the SPRX product. This is absolutely false. There is nothing outstanding about either product. Colorimeters are generic, low-margin devices, and the infant jaundice market is a very tiny niche. There's a good reason the stock suddenly tumbled from 13 a share in the days prior to the distribution agreement and conference call, it's because CCSI insiders and convertible holders are once again dumping on small investors who were late to the party. I expect that the stock will now continue its decline and in the long run will trade at a much more realistic value < 1 a share. For another fine example of what happens to companies that grossly and fraudulently overestimate their market potential - even thought they have an FDA approved product, check out BTIM. I'm sure that this post will draw another barrage of pre-adolescent insults from paid shills and misled investors alike. This doesn't change the facts. Today's conference call affirmed that CCSI has nothing substantive and will most likely never have anything substantive in the way of revenues and earnings.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next